Home > News > ShengdaTech: Small particles lead to big growth
December 20th, 2007
ShengdaTech: Small particles lead to big growth
China in the 21st century conjures up another time of go-go markets, our own Gilded Age when steel, coal and capital fused to create the greatest economy in the world. While China's present boom has something to do with coal and capital, it has as much to do with nanotechnology and university partnerships.
Witness ShengdaTech, Inc. (Nasdaq: SDTH), which is applying 21st century technology to become a new leader in a decidedly old-line business. Shengdatech's leading product is nano precipitated calcium carbonate (NPCC), made from limestone broken down to particles of ~100 nanometer (nm) in size, smaller than the wavelength of visible light.
NPCC is a key filler used in rubber, plastics, paint, ink and as a coating for paper. NPCC is also a key ingredient in the manufacture of automobile tires and PVC building materials, enhancing their tensile strength and durability. Shengdatech is currently the only supplier of NPCC to China's burgeoning tire industry, and they'll buy as much as Shengdatech can make.
News and information
GS7 Graphene Sensor maybe Solution in Fight Against Cancer January 25th, 2015
Toyocolor to Launch New Carbon Nanotube Materials at nano tech 2015 January 24th, 2015
NANOPOSTER 2015 - 5th Virtual Nanotechnology Conference - call for abstracts January 24th, 2015
Nanosensor Used for Simultaneous Determination of Effective Tea Components January 24th, 2015
Fonon Announces 3D Metal Sintering Technology: Emerging Additive Nano Powder Manufacturing Technology August 28th, 2014
INSCX™ exchange launches upgraded Physical Trade Platform December 7th, 2012
Iran's Nanotechnology Capabilities Displayed in Russia Open Innovations Expo 2012 November 10th, 2012
Application of Adamantane November 7th, 2012
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015